Anti-pseudomonas IgY to Prevent Infections in Cystic Fibrosis

Clinical trial NCT00633191 · COMPLETED

Trial details

NCT number: NCT00633191
Sponsor: Immunsystem AB
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Cystic Fibrosis Infection Pseudomonas Aeruginosa

Start date: 2003-11-01
Primary completion: 2012-12-01
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.